At Mid-Decade, Forecasters Taking A Look Into Science And Technology Crystal Ball

Sidebar: A Checklist for Evaluating Forecasts With the year 2000 approaching, scientific, environmental, technology, and health organizations have been making predictions about the state of science and technology in the next five years and beyond, as have some individuals. Many such agencies and associations are also using the approaching turn of the century to set goals for themselves. Should the predictions come true and the goals be met by the start of the next century, forecasters anticipa

Written byKaren Young Kreeger
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

With the year 2000 approaching, scientific, environmental, technology, and health organizations have been making predictions about the state of science and technology in the next five years and beyond, as have some individuals. Many such agencies and associations are also using the approaching turn of the century to set goals for themselves.

Should the predictions come true and the goals be met by the start of the next century, forecasters anticipate, the world will be rid of polio, Internet cruisers will number 200 million, and more minorities will be attending medical school than ever before, among other prognostications.

Andy Hines IN THE HERE AND NOW: "The use of a forecast is really in the present," contents futurist Andy Hines of policy-research firm Coates and Jarratt.

When a prediction "becomes conventional wisdom, for better or worse," says Hines, trouble can arise. One much-hyped, but apparently erroneous, prediction that is still reverberating throughout the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies